Clinical trial
Alteplase for Treatment of Empyema and Complicated Parapneumonic Effusion
NCT00103766 · O'Brien, Jeana D., MD, FACP, FCCP, Other · Unknown status
Key facts
| NCT number | NCT00103766 |
|---|---|
| Title | Alteplase for Treatment of Empyema and Complicated Parapneumonic Effusion |
| Official title | Randomized Comparison of Two Dose and Frequency Regimens of Alteplase for Treatment of Empyema and Complicated Parapneumonic Effusion |
| Lead sponsor | O'Brien, Jeana D., MD, FACP, FCCP, Other |
| Collaborators | Genentech, Inc. Industry Scott and White Hospital & Clinic Scott, Sherwood and Brindley Foundation Texas A&M University |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Empyema, Pleural Effusion |
| Intervention type | Drug |
| Interventions | Alteplase |
| Enrollment | 75 |
| Start date | Oct 1, 2004 |
| First posted | Feb 15, 2005 |
| Last update posted | Aug 1, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: